Sublingual allergen immunotherapy: mode of action and its relationship with the safety profile von Calderón, M. A., Simons, F. E. R., Malling, H.-J., Lockey, R. F., Moingeon, P., Demoly, P.

Volltext

Recommendations for the standardization of clinical outcomes used in allergen immunotherapy trials for allergic rhinoconjunctivitis: an EAACI Position Paper von Pfaar, O, Demoly, P, Gerth van Wijk, R, Bonini, S, Bousquet, J, Canonica, G W, Durham, S R, Jacobsen, L, Malling, H J, Mösges, R, Papadopoulos, N G, Rak, S, Rodriguez del Rio, P, Valovirta, E, Wahn, U, Calderon, M A

Volltext

Standardized testing with chlorhexidine in perioperative allergy – a large single‐centre evaluation von Opstrup, M. S., Malling, H.‐J., Krøigaard, M., Mosbech, H., Skov, P. S., Poulsen, L. K., Garvey, L. H.

Volltext

Recommendations for standardization of clinical trials with Allergen Specific Immunotherapy for respiratory allergy. A statement of a World Allergy Organization (WAO) taskforce von Canonica, G.W, Baena-Cagnani, C.E, Bousquet, J, Bousquet, P.J, Lockey, R.F, Malling, H.-J, Passalacqua, G, Potter, P, Valovirta, E

Volltext

Analysis of allergen immunotherapy studies shows increased clinical efficacy in highly symptomatic patients von Howarth, P., Malling, H.-J., Molimard, M., Devillier, P.

Volltext

Post-treatment efficacy of discontinuous treatment with 300IR 5-grass pollen sublingual tablet in adults with grass pollen-induced allergic rhinoconjunctivitis von Didier, A., Malling, H.-J., Worm, M., Horak, F., Sussman, G., Melac, M., Soulié, S., Zeldin, R. K.

Volltext

Clinical efficacy of sublingual and subcutaneous birch pollen allergen‐specific immunotherapy: a randomized, placebo‐controlled, double‐blind, double‐dummy study von Khinchi, M. S., Poulsen, L. K., Carat, F., André, C., Hansen, A. B., Malling, H.‐J.

Volltext

Side-effects of allergen-specific immunotherapy. A prospective multi-centre study von Winther, L., Arnved, J., Malling, H.-J., Nolte, H., Mosbech, H.

Volltext

Standards for practical allergen‐specific immunotherapy von Alvarez‐Cuesta, E., Bousquet, J., Canonica, G. W., Durham, S. R., Malling, H.‐J., Valovirta, E.

Volltext

European Academy of Allergy and Clinical Immunology task force report on ‘dose–response relationship in allergen‐specific immunotherapy’ von Calderón, M. A., Larenas, D., Kleine‐Tebbe, J., Jacobsen, L., Passalacqua, G., Eng, P. A., Varga, E. M., Valovirta, E., Moreno, C., Malling, H. J., Alvarez‐Cuesta, E., Durham, S., Demoly, P.

Volltext

Efficacy and safety of 5-grass pollen sublingual immunotherapy tablets in patients with different clinical profiles of allergic rhinoconjunctivitis von Malling, H-J., Montagut, A., Melac, M., Patriarca, G., Panzner, P., Seberova, E., Didier, A.

Volltext

Dynamics of plasma levels of specific IgE in chlorhexidine allergic patients with and without accidental re-exposure von Opstrup, M. S., Poulsen, L. K., Malling, H. J., Jensen, B. M., Garvey, L. H.

Volltext

Consensus statement on the treatment of allergic rhinitis von Van Cauwenberge, P., Bachert, C., Passalacqua, G., Bousquet, J., Canonica, G. W., Durham, S. R., Fokkens, W. J., Howarth, P. H., Lund, V., Malling, H.‐J., Mygind, N., Passali, D., Scadding, G. K., Wang, D.‐Y.

Volltext

How to design and evaluate randomized controlled trials in immunotherapy for allergic rhinitis: an ARIA‐GA2LEN statement von Bousquet, J., Schünemann, H. J., Bousquet, P. J., Bachert, C., Canonica, G. W., Casale, T. B., Demoly, P., Durham, S., Carlsen, K.‐H., Malling, H.‐J., Passalacqua, G., Simons, F. E. R., Anto, J., Baena‐Cagnani, C. E., Bergmann, K.‐C., Bieber, T., Briggs, A. H., Brozek, J., Calderon, M. A., Dahl, R., Devillier, P., Gerth van Wijk, R., Howarth, P., Larenas, D., Papadopoulos, N. G., Schmid‐Grendelmeier, P., Zuberbier, T.

Volltext

Allergen immunotherapy: Therapeutic vaccines for allergic diseases A WHO position paper von Bousquet, Jean, Lockey, Richard, Malling, Hans-Jorgen

Volltext

Immunotherapy as an effective tool in allergy treatment von Mailing, H.‐J.

Volltext

EAACI guidelines on allergen immunotherapy: Executive statement von Muraro, A, Roberts, G, Halken, S, Agache, I, Angier, E, Fernandez-Rivas, M, Gerth van Wijk, R, Jutel, M, Lau, S, Pajno, G, Pfaar, O, Ryan, D, Sturm, G J, van Ree, R, Varga, E-M, Bachert, C, Calderon, M, Canonica, G W, Durham, S R, Malling, H J, Wahn, U, Sheikh, A

Volltext

Safety of allergen-specific immunotherapy. Relation between dosage regimen, allergen extract, disease and systemic side-effects during induction treatment von Mellerup, M. T., Hahn, G. W., Poulsen, L. K., Malling, H.-J.

Volltext

The safety and efficacy of subcutaneous birch pollen immunotherapy – a one‐year, randomised, double‐blind, placebo‐controlled study von Bødtger, U., Poulsen, L. K., Jacobi, H. H., Malling, H.‐J.

Volltext

Sublingual immunotherapy: efficacy – methodology and outcome of clinical trials von Malling, H.‐J.

Volltext